
Solvias to Speak at ASGCT 2025 Highlighting Safer Gene Therapy Development
Discussion to Focus on Early Risk Detection, Regulatory Compliance, and Advancing Safer, More Effective Therapies During Cell Line Development KAISERAUGST, Switzerland, May 6, 2025 /PRNewswire/ -- Solvias, a global provider of chemistry, …